Match Document Document Title
US20050234066 Alpha substituted carboxylic acids  
Alpha substituted carboxylic acids of formula (I): wherein R1 and R2 are as defined in the specification and R3 is wherein Y, Ar1, Ar2, Ar3, R4, R5, R6, R7, R8, R9, R9a, R10, R11, R12, R17, ring...
US20130123287 CONTROL AGENT FOR SOFT ROT AND CONTROL METHOD FOR THE SAME  
Providing a novel control agent for soft rot and a novel control method for the same. A compound having no antibacterial activity against Erwinia carotovora but having a control activity against...
US20100075951 Heteroaryls and uses thereof  
This invention provides compounds of formula I: wherein R1, R2, CY, Y1, Y2, X1, X2, and X3 are as described in the specification. The compounds are inhibitors of PI3K and are thus useful for...
US20080096946 Process For The Preparation Of Anastrozole  
A process for the preparation of anastrozole.
US20110275673 INHIBITORS OF SPHINGOSINE KINASE 1  
The invention relates to compounds of Formula (I). Compounds of the present invention are inhibitors of sphingosine kinase 3, and are useful in the treatment of various disorders and conditions,...
US20050169951 Pesticidal composition comprising a lactate ester as crystal growth inhibitor  
The present invention is a method of preventing crystallization of pesticidal compositions during applications by adding a lactate ester as a crystallization preventing agent.
US20100092546 Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds  
Compositions and methods are provided for the treatment of chronic wounds, including, without limitation, pressure ulcers and diabetic ulcers, by transdermal delivery of an agent that increases...
US20130171105 CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUND AND A TOPOISOMERASE II INHIBITOR  
A pharmaceutical combination comprising a topoisomerase II inhibitor, and an Hsp90 inhibitor according to the following formulae a tautomer, or a pharmaceutically acceptable salt thereof, wherein...
US20130156755 CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUNDS AND A VEGF INHIBITOR  
A pharmaceutical combination comprising a VEGF inhibitor, and an Hsp90 inhibitor according to the following formulae (I) or (Ia) a tautomer, or a pharmaceutically acceptable salt thereof, wherein...
US20110171138 SUBSTANTIALLY PURE DEFERASIROX AND PROCESSES FOR THE PREPARATION THEREOF  
Provided herein is a highly pure deferasirox or a pharmaceutically acceptable salt thereof substantially free of hydrazine impurity, 4-hydrazinobenzoic acid, processes for the preparation thereof,...
US20100035929 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF  
Disclosed are dispyrin analogue compounds useful as H3 receptor activity modulators, methods of making same, pharmaceutical compositions comprising same, and methods of treating neurological and...
US20090156602 Organic Compounds  
The invention provides a pharmaceutical combination comprising: a) at least one agent selected from Bcr-Abl, Flt-3, FAK and RAF kinase inhibitors; andb) at least one JAK kinase inhibitor and a...
US20110257166 NOVEL AGROCHEMICAL SUSPOEMULSIONS  
The present invention provides an aqueous suspoemulsion comprising (a) an oil phase comprising (i) at least one triazole active compound as emulsified component, solid at room temperature, (ii) at...
US20140296177 NOVEL ANTIMICROBIAL COMPOUNDS  
A new class of biotin protein ligase (BPL) inhibitors that have antibacterial activity against multiple Staphylococcus aureus isolates, including clinically important methicillin-resistant S....
US20150050241 METHOD OF TREATING VIRAL INFECTIONS  
The present invention is directed to methods and compositions employing 9-(4-hydroxy-2-(hydroxymethyl)butyl)guanine (“H2G”) or derivatives or analogs thereof for the treatment of viral diseases,...
US20050043222 Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application  
Medical combination and its method of topical use comprising active ingredients which are sparingly soluble in water, preferably in one single composition against microbes which are pathogenic in...
US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control  
The present invention relates to methods, compounds, and compositions for inhibiting angiogenesis. More particularly, the present invention relates to methods, compounds, and compositions for...
US20120289505 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE  
The present invention relates to heterocyclic compounds in all their stereoisomeric and tautomeric forms; and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and...
US20080090886 Aqueous Fungicidal Composition And Use Thereof For Combating Harmful Micro Organisms  
The invention relates to aqueous fungicidal active substance compositions and to their use in the control of harmful microorganisms and in particular in the protection of cellulose-comprising...
US20070149588 6-(2,3,6-Trifluorophenyl)triazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds  
The invention relates to 6-(2,3,6-trifluorophenyl)-triazolopyrimidines of formula (I), in which the substituents are defined as follows: R1 represents alkyl, haloalkyl, cycloalkyl, halocycloalkyl,...
US20110111245 Antisapstain compositions comprising a haloalkynl compound, an azole and an unsaturated acid  
The present invention provides antisapstain compositions comprising a haloalkynyl compound, an azole and an unsaturated carboxylic or sulphonic acid. The compositions of the invention are...
US20100120714 SUBSTITUTED BENZENE FUNGICIDES  
Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, wherein W is O or S;V is a direct bond or NR3;Q is or CR6aR6b, O, NR7, C═N—O—R7 or...
US20080261986 PHARMACEUTICAL FORMULATIONS FOR IONTOPHORETIC DELIVERY OF AN ANTI-FUNGAL DRUG  
Pharmaceutical formulations suitable for iontophoresis thereof that provide enhanced iontophoretic delivery of an anti-fungal drug to at least one body surface are described. Also described are...
US20100113607 Pharmaceutical Compositions  
A method for the topical treatment of nail diseases, e.g. onychomycosis, after preparation of the infected nail with a laser beam.
US20080207537 Topical Ungual Formulations  
Application of a reducing agent followed by an oxidising agent to a nail substantially increases the permeability thereof, thereby enabling the passage of drugs across the nail.
US20110104158 DEUTERIUM BEARING ANALOGS OF ANASTROZOLE AS AROMATASE INHIBITORS FOR THE TREATMENT OF BREAST CANCER  
This invention relates to novel, substituted aralkyl heterocyclic compounds according to formula I, their derivatives, pharmaceutically acceptable salts thereof. This invention also provides...
US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor  
Compounds which modulate the CB2 receptor are disclosed. The compounds are useful for treating CB2 receptor-mediated diseases such as pain.
US20080293568 Fungicidal Mixtures  
Fungicidal mixtures, comprising (1) triticonazole of the formula I or salts or adducts thereof and (2) pyraclostrobin of the formula II and (3) at least one acylalanine selected from the group...
US20110166021 Imidazole and Triazole Compounds, the Use Thereof and Preparations Containing These Compounds  
The present invention relates to compounds of the formula I in which the variables have the meanings defined in the claims and in the description.
US20060287360 Novel compounds  
Novel NH-substituted fused triazoles are inhibitors of the bacterial enzyme S aureus methionyl t RNA synthetase and are of use in treating bacterial infections.
US20140322247 CELL PROLIFERATION INHIBITORS AND CONJUGATES THEREOF  
Disclosed herein are immunoconjugates comprising an inhibitor of Eg5 linked to an antigen binding moiety such as an antibody, that are useful for treating cell proliferative disorders. Also...
US20120220455 Azolylmethyloxiranes, Their Use for Controlling Phytopathogenic Fungi and Compositions Comprising Them  
The present invention relates to azolylmethyloxiranes of the general formula I in which A is phenyl which is substituted by an F and another substituent selected from the group consisting of Cl,...
US20080317737 Drug combination for the treatment of skin disorders  
A topical treatment for skin disorders and diseases comprising a combination of at least one antifungal agent and at least one hydroxy acid agent formulated into shampoos, creams, lotions, gels,...
US20080039465 TRIAZOLYL PHENYL BENZENESULFONAMIDES  
Compounds are provided that act as potent antagonists of the CCR2 or CCR9 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for...
US20120270853 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS  
The present invention provides compounds of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, L1, M and R11 are as...
US20140343049 DIHYDROFURAN DERIVATIVES AS INSECTICIDAL COMPOUNDS  
The present invention relates to compounds of formula (IA) wherein QA is QA1 or QA2 P is P1, heterocycyl or heterocyclyl substituted by one to five Z; and wherein A1, A2, A3, A4, G1, Z, R1, R2, R3...
US20080280915 Insecticidal n-substituted (heteroaryl)alkyl sulfilimines  
N-Substituted (heteroaryl)alkyl sulfilimines are effective at controlling insects.
US20110067612 PESTICIDAL COMPOSITION AND METHOD FOR CONTROLLING PEST  
To provide a pesticidal composition which controls a pest undesirable for cultivation of a useful crop plant or a useful plant. A pesticidal composition comprising the following (component A) and...
US20120220638 5-Iodotriazole derivatives  
The present invention relates to novel 5-iodotriazole derivatives, to processes for preparing these compounds, to compositions comprising these compounds, and to the use thereof as biologically...
US20130131061 Novel Estrogen Receptor Ligands  
The invention provides a compound of formula (I) or a pharmaceutically acceptable ester, amide, carbamate, solvate or salt thereof, including a salt of such an ester, amide or carbamate, and a...
US20130281300 Biocide Compositions Comprising Amides Based On 2-Furoic Acid And Its Derivatives  
Suggested are biocide compositions, comprising (a) 2-Furoic and/or Tetrahydro-2-furoic acid amides; (b) Biocides and optionally (c) Oil components or co-solvents and/or (d) Emulsifiers. The...
US20140371066 Synergistic Fungicidal Active Combinations  
Novel active compound combinations comprising a carboxamide of the general formula (I) (group 1) in which A, R1 and R2 are as defined in the description, and the active compound groups (2) to (24)...
US20120077804 Small Molecule Inhibitors of RNA Silencing  
The present invention provides compositions and formulations that contain active compounds as RNAi inhibitors. These compositions and formulations are useful for controlling insects and pests...
US20070299033 Pharmaceutical Co-Crystal Compositions and Related Methods of Use  
The present invention comprises pharmaceutical compositions comprising a co-crystal of an API and a co-crystal former, and methods of making and using the same.
US20110112124 FUNGICIDAL COMPOSITIONS  
A method of controlling phytopathogenic diseases on useful plants or on propagation material thereof, which comprises applying to the useful plants, the locus thereof or propagation material...
US20140080842 SMALL MOLECULE INHIBITORS OF TRPA1  
The present invention relates to the use of compounds which are capable of attenuating skin irritation when they are applied to the skin. Skin irritation can be caused, inter alia, by ingredients...
US20060247280 Compounds and methods  
Compounds of this invention are non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma,...
US20130274110 HYDROPHOBICALLY MODIFIED POLYSACCHARIDE ETHERS AS DEPOSITION ENHANCERS FOR AGRICULTURAL ACTIVE INGREDIENTS  
A composition is provided, comprising a non-ionic, water-soluble, hydrophobically modified lower alkyl hydroxyalkyl linear polysaccharide ether, wherein the hydrophobic group comprises a...
US20090155210 OXIMYL HCV SERINE PROTEASE INHIBITORS  
The present invention discloses compounds of formula I or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit serine protease activity, particularly the activity of...
US20090087480 PHARMACEUTICAL COMPOSITION AND METHOD USING ANTIFUNGAL AGENT IN COMBINATION  
A pharmaceutical composition containing one or more antifungal agents selected from an arylamidine derivative represented by the general formula: (wherein R1 represents an amidino group that may...